These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14737869)

  • 1. [Improvement of action myoclonus in a patient with dentatorubral-pallidoluysian atrophy by piracetam].
    Hirose M; Yokoyama H; Noguchi R; Haginoya K; Aoki M; Iinuma K
    No To Hattatsu; 2004 Jan; 36(1):75-9. PubMed ID: 14737869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
    Hamada S; Shimakawa S; Satomura S; Naito E; Hashimoto T
    No To Hattatsu; 2014 Nov; 46(6):439-42. PubMed ID: 25558587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An established case of dentatorubral pallidoluysian atrophy (DRPLA) with unusual features on muscle biopsy.
    Cox H; Costin-Kelly NM; Ramani P; Whitehouse WP
    Eur J Paediatr Neurol; 2000; 4(3):119-23. PubMed ID: 10872107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical dystonia in dentatorubral-pallidoluysian atrophy.
    Hatano T; Okuma Y; Iijima M; Fujishima K; Goto K; Mizuno Y
    Acta Neurol Scand; 2003 Oct; 108(4):287-9. PubMed ID: 12956864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam in the treatment of cortical myoclonus.
    Genton P; Guerrini R; Remy C
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():49-53. PubMed ID: 10338109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dentatorubral-pallidoluysian atrophy in two Chinese families in Hong Kong.
    Yam WK; Wu NS; Lo IF; Ko CH; Yeung WL; Lam ST
    Hong Kong Med J; 2004 Feb; 10(1):53-6. PubMed ID: 14967857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head tremor in dentatorubral-pallidoluysian atrophy.
    Ohizumi H; Okuma Y; Fukae J; Fujishima K; Goto K; Mizuno Y
    Acta Neurol Scand; 2002 Nov; 106(5):319-21. PubMed ID: 12371928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy.
    Hayashi M; Kumada S; Shioda K; Fukatsu R
    Brain Dev; 2007 Sep; 29(8):473-81. PubMed ID: 17307319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal complications in two patients with dentatorubral-pallidoluysian atrophy.
    Morita T; Kotani H; Ishihara M; Naruse K; Fujieda M; Wakiguchi H; Ogura H
    Clin Nephrol; 2007 Jan; 67(1):44-8. PubMed ID: 17269599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dentatorubral-pallidoluysian atrophy (DRPLA) presenting with psychosis.
    Adachi N; Arima K; Asada T; Kato M; Minami N; Goto Yi ; Onuma T; Ikeuchi T; Tsuji S; Hayashi M; Fukutani Y
    J Neuropsychiatry Clin Neurosci; 2001; 13(2):258-60. PubMed ID: 11449034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of psychosis in dentatorubral-pallidoluysian atrophy with quetiapine: A case report.
    Narita Z; Sumiyoshi T
    Neuropsychopharmacol Rep; 2018 Mar; 38(1):44-46. PubMed ID: 30106267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abolition of photoparoxysmal response in progressive myoclonus epilepsy.
    Paulus W; Ried S; Stodieck SR; Schmidt D
    Eur Neurol; 1991; 31(6):388-90. PubMed ID: 1756763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piracetam in the treatment of myoclonus: an overview.
    Van Vleymen B; Van Zandijcke M
    Acta Neurol Belg; 1996 Dec; 96(4):270-80. PubMed ID: 9008776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter T2 hyperintensity development and clinical deterioration after status epilepticus in a patient with dentatorubral-pallidoluysian atrophy.
    Takamure M; Hirano M; Taoka T; Ueno S
    Clin Neurol Neurosurg; 2006 Jul; 108(5):482-5. PubMed ID: 16720221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto encephalopathy presenting as progressive myoclonus epilepsy syndrome.
    Arya R; Anand V; Chansoria M
    Eur J Paediatr Neurol; 2013 Jan; 17(1):102-4. PubMed ID: 22840275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pharmacological profile of piracetam (Myocalm), a drug for myoclonus].
    Tajima K; Nanri M
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):209-14. PubMed ID: 11084917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A severe case of dentatorubro-pallidoluysian atrophy (DRPLA) with microcephaly, very early onset of seizures, and cerebral white matter involvement.
    Brunetti-Pierri N; Wilfong AA; Hunter JV; Craigen WJ
    Neuropediatrics; 2006 Oct; 37(5):308-11. PubMed ID: 17236112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first identified French family with dentatorubral-pallidoluysian atrophy.
    Destée A; Delalande I; Vuillaume I; Schraen-Maschke S; Defebvre L; Sablonnière B
    Mov Disord; 2000 Sep; 15(5):996-9. PubMed ID: 11009212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.